Trial Profile
Phase II Study of Temozolomide in Unresectable or Metastatic Gastrointestinal Stromal Tumors (GIST)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Apr 2023
Price :
$35
*
At a glance
- Drugs Temozolomide (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- 15 Jan 2013 New trial record